Daniel Visscher
Overview
Explore the profile of Daniel Visscher including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
22
Citations
2706
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Multinu F, Chen J, Madison J, Torres M, Casarin J, Visscher D, et al.
Gynecol Oncol
. 2020 Jan;
156(3):682-688.
PMID: 31902687
Objective: To determine whether analysis of methylated DNA in benign endometrial biopsy (EB) specimens is associated with risk of endometrial cancer (EC). Methods: We identified 23 women with EBs performed...
2.
Solanki M, Visscher D
Hum Pathol
. 2019 Nov;
95:137-148.
PMID: 31682887
The past 50 years has been an era of technological innovation converging with the now dominant culture of testing hypotheses using clinical trials and case cohort methodology with rigorous statistical...
3.
Yaghjyan L, Stoll E, Ghosh K, Scott C, Jensen M, Brandt K, et al.
Breast Cancer Res
. 2017 Aug;
19(1):100.
PMID: 28851411
Background: Mammographic breast density is a well-established, strong breast cancer risk factor but the biology underlying this association remains unclear. Breast density may reflect underlying alterations in the size and...
4.
Prevention of Human Lymphoproliferative Tumor Formation in Ovarian Cancer Patient-Derived Xenografts
Butler K, Hou X, Becker M, Zanfagnin V, Enderica-Gonzalez S, Visscher D, et al.
Neoplasia
. 2017 Jun;
19(8):628-636.
PMID: 28658648
Interest in preclinical drug development for ovarian cancer has stimulated development of patient-derived xenograft (PDX) or tumorgraft models. However, the unintended formation of human lymphoma in severe combined immunodeficiency (SCID)...
5.
Yaghjyan L, Tamimi R, Bertrand K, Scott C, Jensen M, Pankratz V, et al.
Breast Cancer Res Treat
. 2017 Jun;
165(2):421-431.
PMID: 28624977
Purpose: We examined the associations of mammographic breast density with breast cancer risk by tumor aggressiveness and by menopausal status and current postmenopausal hormone therapy. Methods: This study included 2596...
6.
Howat W, Blows F, Provenzano E, Brook M, Morris L, Gazinska P, et al.
J Pathol Clin Res
. 2016 Aug;
1(1):18-32.
PMID: 27499890
Breast cancer risk factors and clinical outcomes vary by tumour marker expression. However, individual studies often lack the power required to assess these relationships, and large-scale analyses are limited by...
7.
Figueroa J, Pfeiffer R, Brinton L, Palakal M, Degnim A, Radisky D, et al.
Breast Cancer Res Treat
. 2016 Aug;
159(1):163-72.
PMID: 27488681
Lesser degrees of terminal duct-lobular unit (TDLU) involution predict higher breast cancer risk; however, standardized measures to quantitate levels of TDLU involution have only recently been developed. We assessed whether...
8.
Sobral-Leite M, Wesseling J, Smit V, Nevanlinna H, van Miltenburg M, Sanders J, et al.
BMC Med
. 2015 Jul;
13:156.
PMID: 26137966
Background: Annexin A1 (ANXA1) is a protein related with the carcinogenesis process and metastasis formation in many tumors. However, little is known about the prognostic value of ANXA1 in breast...
9.
Figueroa J, Pfeiffer R, Patel D, Linville L, Brinton L, Gierach G, et al.
J Natl Cancer Inst
. 2014 Oct;
106(10).
PMID: 25274491
Background: Greater degrees of terminal duct lobular unit (TDLU) involution have been linked to lower breast cancer risk; however, factors that influence this process are poorly characterized. Methods: To study...
10.
Kaur J, Vierkant R, Hobday T, Visscher D
Cancer Epidemiol Biomarkers Prev
. 2014 Mar;
23(3):409-15.
PMID: 24609850
Background: Breast cancer is not a homogeneous disease, but several different and unique subtypes defined by gene expression analysis. Incidence and mortality rates vary by almost 3-fold between Alaska (highest)...